{"transactions":[{"id":1821889,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Option (Right to Buy Common Shares)","published_at":"2023-07-28T18:30:51.000Z","date":"2023-07-27","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on July 27, 2023 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated July 27, 2023 (the \"Option Agreement\"). 25% of the options vest and become exercisable on the one-year anniversary of the Grant Date, with the remaining 75% of the options vesting and becoming exercisable in 24 equal monthly installments beginning on the first day of the month following the one-year anniversary of the Grant Date, subject to the reporting person's employment on the relevant vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":70000,"derivative":{"exercise_price":1.3,"expiration_date":"2033-07-27","underlying":"Common Shares","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001493152-23-025954","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315223025954/ownership.xml","form_type":"4"}},{"id":2043105,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Option (Right to Buy Common Shares)","published_at":"2023-01-30T17:02:28.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on January 26, 2023 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 26, 2023 (the \"Option Agreement\"). 25% of the options vest and become exercisable on the one-year anniversary of the Grant Date, with the remaining 75% of the options vesting and becoming exercisable in 24 equal monthly installments beginning on the first day of the month following the one-year anniversary of the Grant Date, subject to the reporting person's employment on the relevant vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":100000,"derivative":{"exercise_price":0.575,"expiration_date":"2033-01-26","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-23-002981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315223002981/ownership.xml","form_type":"4"}},{"id":2421885,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Option (Right to Buy Common Shares)","published_at":"2022-01-31T17:40:13.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on January 27, 2022 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 27, 2022 (the \"Option Agreement\"). 25% of the options vest and become exercisable on the one-year anniversary of the Grant Date, with the remaining 75% of the options vesting and becoming exercisable in 24 equal monthly installments beginning on the first day of the month following the one-year anniversary of the Grant Date, subject to the reporting person's employment on the relevant vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":800000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-01-27","underlying":"Common Shares","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001493152-22-002773","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315222002773/ownership.xml","form_type":"4"}},{"id":2658433,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2021-06-22T21:28:05.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 100% on June 17, 2022"}],"balance_after":20000,"derivative":{"exercise_price":9.99,"exercise_date":"2022-06-17","expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001628280-21-012676","document":"wf-form4_162439725270272.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828021012676/wf-form4_162439725270272.xml","form_type":"4"}},{"id":2891554,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Option (Right to Buy Common Shares)","published_at":"2021-01-29T18:09:57.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on January 27, 2021 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 27, 2021 (the \"Option Agreement\"). 25% of the options vest and become exercisable on the one-year anniversary of the Grant Date, with the remaining 75% of the options vesting and becoming exercisable in 24 equal monthly installments beginning on the first day of the month following the one-year anniversary of the Grant Date, subject to the reporting person's employment on the relevant vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":1000000,"derivative":{"exercise_price":3.15,"expiration_date":"2031-01-27","underlying":"Common Shares","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001493152-21-002138","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315221002138/ownership.xml","form_type":"4"}},{"id":3094238,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Option (Right to Buy Common Shares)","published_at":"2020-07-02T17:15:16.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":425200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on July 1, 2020 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated July 1, 2020 (the \"Option Agreement\"). 25% of the options vest and become exercisable on the one-year anniversary of the Grant Date, with the remaining 75% of the options vesting and becoming exercisable in 24 equal monthly installments beginning on the first day of the month following the one-year anniversary of the Grant Date, subject to the reporting person's employment on the relevant vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":425200,"derivative":{"exercise_price":2.94,"expiration_date":"2030-07-01","underlying":"Common Shares","underlying_shares":425200},"source":{"system":"sec-edgar","filing":"0001493152-20-012553","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315220012553/ownership.xml","form_type":"4"}},{"id":3102853,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2020-06-23T01:21:13.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 100% on June 19, 2021."}],"balance_after":20000,"derivative":{"exercise_price":4.67,"exercise_date":"2021-06-19","expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-20-001667","document":"form4-06222020_060659.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000141588920001667/form4-06222020_060659.xml","form_type":"4"}},{"id":3303622,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Option (Right to Buy Common Shares)","published_at":"2020-01-24T17:19:39.000Z","date":"2020-01-22","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on January 22, 2020 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 22, 2020 (the \"Option Agreement\"). The options vest and become exercisable in 36 equal monthly installments beginning on the first day of the month following the Grant Date, subject to the reporting person's employment on the relevant vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":500000,"derivative":{"exercise_price":1.46,"expiration_date":"2030-01-22","underlying":"Common Shares","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-20-001072","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315220001072/ownership.xml","form_type":"4"}},{"id":3404932,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Shares, no par value per share","published_at":"2019-09-30T16:22:25.000Z","date":"2019-09-30","kind":"purchase","acquired":true,"shares":150000,"price":0.503,"value":75450.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average price of shares purchased in multiple transactions at prices ranging from $0.4976 to $0.509, inclusive. The reporting person undertakes to provide to VBI Vaccines Inc., any security holder of VBI Vaccines Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":608255,"source":{"system":"sec-edgar","filing":"0001493152-19-014759","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315219014759/ownership.xml","form_type":"4"}},{"id":3479814,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2019-06-25T00:32:10.000Z","date":"2019-06-21","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 100% on June 21, 2020."}],"balance_after":20000,"derivative":{"exercise_price":3.8,"exercise_date":"2020-06-21","expiration_date":"2029-06-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-19-000792","document":"form4-06242019_050657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000141588919000792/form4-06242019_050657.xml","form_type":"4"}},{"id":3485415,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Shares, no par value per share","published_at":"2019-06-19T12:17:52.000Z","date":"2019-06-19","kind":"purchase","acquired":true,"shares":144000,"price":0.7315,"value":105336.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average price of shares purchased in multiple transactions at prices ranging from $0.7199 to $0.748, inclusive. The reporting person undertakes to provide to VBI Vaccines Inc., any security holder of VBI Vaccines Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":458255,"source":{"system":"sec-edgar","filing":"0001493152-19-009422","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315219009422/ownership.xml","form_type":"4"}},{"id":3487152,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2019-06-18T16:14:46.000Z","date":"2019-06-14","kind":"exercise","acquired":false,"shares":31250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested 1/3 per year annually over 3 years, beginning on June 14, 2017, subject to continued service through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested 1/3 per year annually over 3 years, beginning on June 14, 2017, subject to continued service through each vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001493152-19-009383","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315219009383/ownership.xml","form_type":"4"}},{"id":3487151,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Shares, no par value per share","published_at":"2019-06-18T16:14:46.000Z","date":"2019-06-14","kind":"exercise","acquired":true,"shares":31250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."}],"balance_after":314255,"source":{"system":"sec-edgar","filing":"0001493152-19-009383","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315219009383/ownership.xml","form_type":"4"}},{"id":3678866,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Option (Right to Buy Common Shares)","published_at":"2019-02-04T17:17:23.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on January 31, 2019 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 31, 2019 (the \"Option Agreement\"). The options vest and become exercisable in 36 equal monthly installments beginning on the first day of the month following the Grant Date, subject to the reporting person's employment on the relevant vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":450000,"derivative":{"exercise_price":1.67,"expiration_date":"2029-01-31","underlying":"Common Shares","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001493152-19-001340","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315219001340/ownership.xml","form_type":"4"}},{"id":3678865,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Shares, no par value per share","published_at":"2019-02-04T17:17:23.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":283005,"source":{"system":"sec-edgar","filing":"0001493152-19-001340","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315219001340/ownership.xml","form_type":"4"}},{"id":3851467,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Shares, no par value per share","published_at":"2018-08-07T20:38:12.000Z","date":"2018-08-06","kind":"purchase","acquired":true,"shares":8100,"price":1.9268,"value":15607.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average price of shares purchased in multiple transactions at prices ranging from $1.9267 to $1.929, inclusive. The reporting person undertakes to provide to VBI Vaccines Inc., any security holder of VBI Vaccines Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":233005,"source":{"system":"sec-edgar","filing":"0001493152-18-011114","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315218011114/ownership.xml","form_type":"4"}},{"id":3852562,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Shares, no par value per share","published_at":"2018-08-06T11:06:31.000Z","date":"2018-08-03","kind":"purchase","acquired":true,"shares":13500,"price":2.0082,"value":27110.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average price of shares purchased in multiple transactions at prices ranging from $1.9956 to $2.1054, inclusive. The reporting person undertakes to provide to VBI Vaccines Inc., any security holder of VBI Vaccines Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":224905,"source":{"system":"sec-edgar","filing":"0001493152-18-010980","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315218010980/ownership.xml","form_type":"4"}},{"id":3857420,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Shares, no par value per share","published_at":"2018-08-01T13:39:55.000Z","date":"2018-07-31","kind":"purchase","acquired":true,"shares":16800,"price":2.276,"value":38236.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average price of shares purchased in multiple transactions at prices ranging from $2.21 to $2.32, inclusive. The reporting person undertakes to provide to VBI Vaccines Inc., any security holder of VBI Vaccines Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":211405,"source":{"system":"sec-edgar","filing":"0001493152-18-010786","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315218010786/ownership.xml","form_type":"4"}},{"id":3882880,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-06-26T21:11:54.000Z","date":"2018-06-22","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 100% on June 22, 2019."}],"balance_after":20000,"derivative":{"exercise_price":3.83,"exercise_date":"2019-06-22","expiration_date":"2028-06-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-18-001030","document":"form4-06262018_020638.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000141588918001030/form4-06262018_020638.xml","form_type":"4"}},{"id":3891822,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2018-06-18T10:44:04.000Z","date":"2018-06-14","kind":"exercise","acquired":false,"shares":31250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest 1/3 per year annually over 3 years, beginning on June 14, 2017, subject to continued service through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest 1/3 per year annually over 3 years, beginning on June 14, 2017, subject to continued service through each vesting date."}],"balance_after":31250,"derivative":{"underlying":"Common Shares","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001493152-18-008812","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315218008812/form4.xml","form_type":"4"}},{"id":3891821,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Shares, no par value per share","published_at":"2018-06-18T10:44:04.000Z","date":"2018-06-14","kind":"exercise","acquired":true,"shares":31250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."}],"balance_after":194605,"source":{"system":"sec-edgar","filing":"0001493152-18-008812","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315218008812/form4.xml","form_type":"4"}},{"id":3918044,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Shares, no par value per share","published_at":"2018-05-25T13:54:17.000Z","date":"2018-05-24","kind":"purchase","acquired":true,"shares":11000,"price":2.99,"value":32890.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average price of shares purchased in multiple transactions at prices ranging from $2.945 to $3.0099, inclusive. The reporting person undertakes to provide to VBI Vaccines Inc., any security holder of VBI Vaccines Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":163355,"source":{"system":"sec-edgar","filing":"0001493152-18-007825","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315218007825/form4.xml","form_type":"4"}},{"id":3936336,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Shares, no par value per share","published_at":"2018-05-14T16:54:48.000Z","date":"2018-05-11","kind":"purchase","acquired":true,"shares":7100,"price":2.91,"value":20661.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average price of shares purchased in multiple transactions at prices ranging from $2.9088 to $2.919, inclusive. The reporting person undertakes to provide to VBI Vaccines Inc., any security holder of VBI Vaccines Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":152355,"source":{"system":"sec-edgar","filing":"0001493152-18-006815","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315218006815/form4.xml","form_type":"4"}},{"id":4090476,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Option (Right to Buy Common Shares)","published_at":"2018-01-25T14:26:06.000Z","date":"2018-01-23","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on January 23, 2018 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 23, 2018 (the \"Option Agreement\"). The options vest and become exercisable in 36 equal monthly installments beginning on the first day of the month following the Grant Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":150000,"derivative":{"exercise_price":4.19,"expiration_date":"2028-01-23","underlying":"Common Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-18-001025","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315218001025/form4.xml","form_type":"4"}},{"id":4134219,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Shares, no par value per share","published_at":"2017-12-13T17:21:50.000Z","date":"2017-12-12","kind":"purchase","acquired":true,"shares":4609,"price":3.88,"value":17882.92,"ownership":{"direct":true},"balance_after":145255,"source":{"system":"sec-edgar","filing":"0001493152-17-014574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315217014574/form4.xml","form_type":"4"}},{"id":4134218,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Shares, no par value per share","published_at":"2017-12-13T17:21:50.000Z","date":"2017-12-12","kind":"purchase","acquired":true,"shares":5391,"price":3.89,"value":20970.99,"ownership":{"direct":true},"balance_after":140646,"source":{"system":"sec-edgar","filing":"0001493152-17-014574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315217014574/form4.xml","form_type":"4"}},{"id":4149784,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Shares, no par value per share","published_at":"2017-11-29T14:31:00.000Z","date":"2017-11-28","kind":"purchase","acquired":true,"shares":15000,"price":4.75,"value":71250.0,"ownership":{"direct":true},"balance_after":135255,"source":{"system":"sec-edgar","filing":"0001493152-17-013934","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315217013934/form4.xml","form_type":"4"}},{"id":4228192,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Shares, no par value per share","published_at":"2017-08-22T16:20:21.000Z","date":"2017-08-21","kind":"purchase","acquired":true,"shares":10000,"price":3.22,"value":32200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average price of shares purchased in multiple transactions at prices ranging from $3.18 to $3.24, inclusive. The reporting person undertakes to provide to VBI Vaccines Inc., any security holder of VBI Vaccines Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":120255,"source":{"system":"sec-edgar","filing":"0001493152-17-009728","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315217009728/form4.xml","form_type":"4"}},{"id":4236060,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Shares, no par value per share","published_at":"2017-08-14T16:42:43.000Z","date":"2017-08-10","kind":"purchase","acquired":true,"shares":10000,"price":3.28,"value":32800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average price of shares purchased in multiple transactions at prices ranging from $3.21 to $3.33, inclusive. The reporting person undertakes to provide to VBI Vaccines Inc., any security holder of VBI Vaccines Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":110255,"source":{"system":"sec-edgar","filing":"0001493152-17-009246","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315217009246/form4.xml","form_type":"4"}},{"id":4261513,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2017-07-06T20:44:54.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 100% on June 20, 2018."}],"balance_after":20000,"derivative":{"exercise_price":3.59,"exercise_date":"2018-06-20","expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-17-001139","document":"form4-07062017_010743.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000141588917001139/form4-07062017_010743.xml","form_type":"4"}},{"id":4280132,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2017-06-16T17:53:00.000Z","date":"2017-06-14","kind":"exercise","acquired":false,"shares":31250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest 1/3 per year over 3 years, beginning on June 14, 2017, subject to continued service through each vesting date."}],"balance_after":62500,"derivative":{"expiration_date":"2026-06-14","underlying":"Common Shares","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001493152-17-006774","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315217006774/form4.xml","form_type":"4"}},{"id":4280131,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Common Shares, no par value per share","published_at":"2017-06-16T17:53:00.000Z","date":"2017-06-14","kind":"exercise","acquired":true,"shares":31250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."}],"balance_after":100255,"source":{"system":"sec-edgar","filing":"0001493152-17-006774","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315217006774/form4.xml","form_type":"4"}},{"id":4344187,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Option (Right to Buy Common Shares)","published_at":"2017-04-27T21:56:56.000Z","date":"2017-04-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on January 26, 2017 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated April 18, 2017 (the \"Option Agreement\"). The options vest and become exercisable in 48 equal monthly installments beginning on the first day of the month following the Grant Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":20000,"derivative":{"exercise_price":3.79,"expiration_date":"2027-01-26","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-17-004496","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315217004496/form4.xml","form_type":"4"}},{"id":4350263,"issuer":{"id":154844,"kind":"organization","name":"VBI VACCINES INC.","symbol":"VBIV"},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Option (Right to Buy Common Shares)","published_at":"2017-04-19T20:56:13.000Z","date":"2017-04-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on January 26, 2017 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated April 18, 2017 (the \"Option Agreement\"). The options vest and become exercisable in 48 equal monthly installments beginning on the first day of the month following the Grant Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":20000,"derivative":{"exercise_price":3.79,"expiration_date":"2027-01-26","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-17-004199","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704159/000149315217004199/form4.xml","form_type":"4"}},{"id":4548536,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":111069,"kind":"person","name":"Baxter Jeff","position":1,"cik":"0001615941","reported_name":"Baxter Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Options (right to buy)","published_at":"2016-11-18T21:39:08.000Z","date":"2016-11-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 100% on November 16, 2017."}],"balance_after":20000,"derivative":{"exercise_price":2.605,"exercise_date":"2017-11-16","expiration_date":"2026-11-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-16-007478","document":"form4-11182016_011158.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000141588916007478/form4-11182016_011158.xml","form_type":"4"}}]}